Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
OptiBroc
- Development stage
- Unknown
- Lead developer
- 4Potentia
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
OptiBroc is a proprietary broccoli seed extract developed by 4Potentia, standardized for its high content of glucoraphanin (also known as sulforaphane glucosinolate). As a natural dietary supplement ingredient, it serves as a stable precursor to sulforaphane, a potent bioactive isothiocyanate. The primary mechanism of action involves the activation of the Nuclear factor erythroid 2-related factor 2 (Nrf2) signaling pathway. Upon conversion to sulforaphane, it triggers the cellular antioxidant response element (ARE), leading to the upregulation of Phase II detoxification enzymes and antioxidant proteins such as glutathione S-transferase and quinone reductase. OptiBroc is designed for use in nutraceutical formulations aimed at supporting cellular health, metabolic function, and systemic detoxification.
- Brand names
- OptiBroc
- Other names
- broccoli seed extractglucoraphanin
02
Targets
NFE2L2 (Nuclear factor (erythroid-derived 2)-like 2)
Beyond the preview
Go deeper on OptiBroc.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on OptiBroc.